Handgrip Strength is more associated with blood glucose than ACE and AGT polymorphisms in hemodialysus patients

Background: Patients with chronic kidney disease (CKD) often present with comorbidities like hypertension and diabetes. These conditions are often associated with loss of strength, which is a strong predictor of mortality. In this sense, it is reasonable to investigate genetic and physiological markers that could be related to strength and identify variables associated with this phenomenon. Objective: This study aimed to investigate the influence of angiotensin-1 converting enzyme (ACE) and angiotensinogen (AGT) M235T polymorphisms, and blood glucose on handgrip strength (HGS) for CKD patients with and without diabetes mellitus (DM). Methods: Male patients (n = 84) participated in this cross-sectional study. Patients were grouped based on the diagnosis of DM or not.  We evaluated HGS using a dynamometer and ACE and AGT polymorphism by polymerase chain reaction. Results: There were differences in HGS between groups. Follow up analyses indicated a difference in the distribution of ACE polymorphism alleles was associated with the reduction in HGS in the DM group. The same response was present for AGT. A negative correlation existed between blood glucose levels and HGS (r = -0.334 with p < 0.05). Discussion: The present data suggests that there is a relationship between physical capacity and poor glycemic control. Conclusion: Our study demonstrated that blood glucose levels are associated with HGS in patients with CKD independent of ACE I/D and AGT M235T polymorphisms. Presence of DM may influence functional strength retention.

[1]  J. Carrero,et al.  Muscle wasting in end-stage renal disease promulgates premature death: established, emerging and potential novel treatment strategies. , 2016, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  A. Bahrampour,et al.  Association of Handgrip Strength With Malnutrition-Inflammation Score as an Assessment of Nutritional Status in Hemodialysis Patients. , 2016, Iranian journal of kidney diseases.

[3]  R. Kumaresan,et al.  Prevalence of angiotensin converting enzyme (ACE) gene insertion/deletion polymorphism in South Indian population with hypertension and chronic kidney disease , 2015, Journal of postgraduate medicine.

[4]  K. Charlton,et al.  Lean Body Mass Associated with Upper Body Strength in Healthy Older Adults While Higher Body Fat Limits Lower Extremity Performance and Endurance , 2015, Nutrients.

[5]  T. Eisenberger,et al.  An Efficient and Comprehensive Strategy for Genetic Diagnostics of Polycystic Kidney Disease , 2015, PloS one.

[6]  Yu-jing Wang,et al.  The M235T polymorphism in the angiotensinogen gene and myocardial infarction risk: A meta-analysis , 2014, Journal of the renin-angiotensin-aldosterone system : JRAAS.

[7]  D. Jones,et al.  The individual and combined influence of ACE and ACTN3 genotypes on muscle phenotypes before and after strength training , 2014, Scandinavian journal of medicine & science in sports.

[8]  L. H. A. Salis,et al.  Survival and Predictive Factors of Lethality in Hemodyalisis: D/I Polymorphism of The Angiotensin I-Converting Enzyme and of the Angiotensinogen M235T Genes , 2014, Arquivos brasileiros de cardiologia.

[9]  M. Kaczmarczyk,et al.  Association of rs699 (M235T) Polymorphism in the AGT Gene With Power but Not Endurance Athlete Status , 2013, Journal of strength and conditioning research.

[10]  Tian-biao Zhou,et al.  Association of angiotensinogen M235T gene polymorphism with end-stage renal disease risk: a meta-analysis , 2013, Molecular Biology Reports.

[11]  A. Lucia,et al.  Single and combined influence of ACE and ACTN3 genotypes on muscle phenotypes in octogenarians , 2012, European Journal of Applied Physiology.

[12]  Roberto Tatsuya Saito Metodologia da pesquisa científica , 2012 .

[13]  E. Cavalheiro,et al.  Carbamazepine inhibits angiotensin I-converting enzyme, linking it to the pathogenesis of temporal lobe epilepsy , 2012, Translational Psychiatry.

[14]  Josef Coresh,et al.  Chronic kidney disease , 2012, The Lancet.

[15]  How-Ran Guo,et al.  Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  林清淵 Handgrip strength is an independent predictor of renal outcomes in patients with chronic kidney diseases , 2011 .

[17]  G. Selvam,et al.  Analysis of polymorphism in renin angiotensin system and other related genes in South Indian chronic kidney disease patients. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[18]  M. D. de Vasconcellos,et al.  Reference values of handgrip dynamometry of healthy adults: a population-based study. , 2008, Clinical nutrition.

[19]  B. Hurley,et al.  ACE genotype and the muscle hypertrophic and strength responses to strength training. , 2008, Medicine and science in sports and exercise.

[20]  G. Gill,et al.  Aerobic fitness and hand grip strength in Type 1 diabetes: relationship to glycaemic control and body composition , 2007, Diabetic Medicine.

[21]  J. Chan,et al.  Cardiac hypertrophy and remodeling in relation to ACE and angiotensinogen genes genotypes in Chinese dialysis patients. , 2003, Kidney international.

[22]  J. Fonseca Metodologia da Pesquisa Científica. , 2002 .

[23]  F. Frey,et al.  Genetic polymorphisms of the renin-angiotensin-aldosterone system in end-stage renal disease. , 2001, Kidney international.

[24]  F. Guillemin,et al.  Polymorphism of angiotensin converting enzyme, angiotensinogen, and angiotensin II type 1 receptor genes and end-stage renal failure in IgA nephropathy: IGARAS--a study of 274 Men. , 2000, Journal of the American Society of Nephrology : JASN.

[25]  David A Jones,et al.  Angiotensin‐Converting Enzyme Genotype Affects the Response of Human Skeletal Muscle to Functional Overload , 2000, Experimental physiology.

[26]  M. Margaglione,et al.  Polymorphism of the Angiotensin-Converting Enzyme Gene in End-Stage Renal Failure Patients , 2000, Nephron.

[27]  M. Breuning,et al.  The angiotensin-converting enzyme genotype and microalbuminuria in autosomal dominant polycystic kidney disease. , 1999, Journal of the American Society of Nephrology : JASN.

[28]  R. Torra,et al.  Influence of the ACE gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease. , 1999, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[29]  D. Moczulski,et al.  Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. , 1998, Hypertension.

[30]  P. Holmans,et al.  Association of the angiotensin I converting enzyme gene deletion polymorphism with early onset of ESRF in PKD1 adult polycystic kidney disease. , 1997, Kidney international.

[31]  K. Thai,et al.  Association of angiotensinogen gene T235 variant with progression of immunoglobin A nephropathy in Caucasian patients. , 1997, The Journal of clinical investigation.

[32]  V. Giusti,et al.  Influences of body weight, body composition, and substrate oxidation rate on resting postabsorptive glucose production and gluconeogenesis. , 1996, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[33]  J. Jakobsen,et al.  Isokinetic Muscle Strength in Long-Term IDDM Patients in Relation to Diabetic Complications , 1996, Diabetes.

[34]  P. Valensi,et al.  Cardiac autonomic function in obese patients. , 1995, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[35]  J. Kent‐Braun,et al.  Muscle atrophy in patients receiving hemodialysis: effects on muscle strength, muscle quality, and physical function. , 2003, Kidney international.

[36]  Sung Gyoo Park Medicine and Science in Sports and Exercise , 1981 .